More than 1050 clinical trials are registered at FDA. gov that explore multipotent
mesenchymal stromal cells (MSCs) for nearly every clinical application imaginable …

The arrival of cell-based therapies is a revolution in medicine. However, its safe clinical
application in a rational manner depends on reliable, clinically applicable methods for …

A large number of clinical trials have shown stem cell therapy to be a promising therapeutic
approach for the treatment of cardiovascular diseases. Since the first transplantation into …

Intravenous (IV) stem cell delivery for regenerative tissue therapy has been increasingly
used in both experimental and clinical trials. However, recent data suggest that the majority …

In regenerative medicine, clinical imaging is indispensable for characterizing damaged
tissue and for measuring the safety and efficacy of therapy. However, the ability to track the …

Although cellular therapies hold great promise for the treatment of human disease, results
from several initial clinical trials have not shown a level of efficacy required for their use as a …

Myocardial regeneration using stem and progenitor cell transplantation in the injured heart
has recently become a major goal in the treatment of cardiac disease. Experimental studies …

BACKGROUND: Several animal and few human studies suggest the beneficial role of bone
marrow mesenchymal stem cells (MSCs) in liver cirrhosis. However, little is known about the …

Positron emission particle tracking (PEPT) is a technique which allows the high-resolution,
three-dimensional imaging of particulate and multiphase systems, including systems which …

Cell therapies are increasingly recognized as a promising option to augment the limited
therapeutic arsenal available to fight ischemic stroke. During the last two decades …